159 results on '"Morishita, Ryuichi"'
Search Results
2. PS-BPB03-5: DEVELOPMENT OF A THERAPEUTIC VACCINE FOR DYSLIPIDEMIA AND RELATED DISEASES TARGETING ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3).
3. PS-B08-9: INHIBITION OF PERIOSTIN PROTECTED FROM EXACERBATION OF INFLAMMATION IN RHABDOMYOLYSIS-INDUCED ACUTE KIDNEY INJURY
4. PS-C01-12: EARLY DETECTION OF DEMENTIA USING AI-BASED EYE-TRACKING TECHNOLOGY
5. PS-R04-8: DIFFERENTIAL RECOVERY OF IMPAIRED ENDOTHELIAL AND RENAL FUNCTION IN A CASE OF MALIGNANT HYPERTENSION
6. PS-B10-12: A NOVEL PLATFORM FOR A LARGE-VOLUME CSF COLLECTION IN THE FREE-BEHAVING MICE AS A PRECLINICAL MODEL FOR BIOMARKER DEVELOPMENT.
7. PS-B05-10: DIABETES MELLITUS AGGRAVATES BEHAVIORAL DEFICIT AND INCREASES SITE-SPECIFIC PHOSPHORYLATION OF TAU PROTEIN IN ALZHEIMER'S DISEASE MOUSE MODEL
8. PS-BPB07-1: DEVELOPMENT OF ANTI-THROMBOTIC VACCINE AGAINST HUMAN S100A9
9. CD153 VACCINE IS A NOVEL SENOTHERAPEUTIC OPTION FOR REMOVING SENESCENCE-ASSOCIATED T CELLS
10. NOVEL PATHOPHYSIOLOGICAL ROLES OF ALPHA-SYNUCLEIN (SNCA) IN AGE-RELATED VASCULAR ENDOTHELIAL DYSFUNCTION
11. Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model
12. Progress of Gene Therapy in Cardiovascular Disease
13. A novel angiotensin II peptide vaccine without an adjuvant in mice
14. Abstract WMP78: The Efficacy of Angiotensin II Peptide Vaccination Against White Matter Lesions of Vascular Dementia in Rats
15. Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice
16. Recent Advances in Therapeutic Vaccines to Treat Hypertension
17. A7021 LCZ696, an Angiotensin Receptor with Neprilysin Inhibitor, Attenuates Renal Fibrosis and Glomerular Injury in a Mouse Model of Salt-sensitive Hypertension Using Angiotensin 1 Receptor Knockout Mouse
18. A6251 Periostin splicing variant regulates cardiac fibrosis after myocardial infarction
19. Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model
20. Association between renin–angiotensin–aldosterone system blockade and future osteoporotic fracture risk in hypertensive population
21. Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress
22. Abstract 145: Development of Novel S100A9 Peptide Vaccine for Prevention of Thrombus Formation in Ischemic Stroke in Mice
23. Abstract TP77: New treatment
24. MPS 13-01 NOVEL THERAPEUTIC APPROACH FOR CEREBRAL ISCHEMIA IN RATS WITH ANGIOTENSIN II PEPTIDE VACCINE
25. PS 13-10 INDUCTION OF ANGIOGENESIS BY A TYPE III PHOSPHODIESTERASE INHIBITOR THROUGH ACTIVATION OF PPAR GAMMA AND cAMP PATHWAYS
26. SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION
27. OS 17-05 DEVELOP A THERAPEUTIC VACCINE FOR ANGIOTENSIN II
28. PS 04-20 SELECTIVE BLOCKADE OF PERIOSTIN EXON-17 IMPROVES CARDIAC PERFORMANCE IN RAT MYOCARDIAL ISCHEMIA MODEL
29. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells
30. Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction
31. Abstract TP269: Therapeutic Application of an Angiotensin II Peptide Vaccine in a Middle Cerebral Artery Occlusion Model in Rats
32. Abstract 174: Development of a Novel Anti-inflammatory and Anti-osteoplastic Peptide Based on De-loop and Ef-loop in Rankl for Treatment of Ischemic Stroke
33. Abstract 18871: Coagulation Factor Xa Promotes Endothelial Cell Senescence Via P53 Up-regulation
34. Abstract 10200: Translational Research of Novel Angiogenic Peptide for Wound Healing Drug; From Discovery to Clinical Trial
35. Abstract 13742: PDE3 Inhibitor, Cilostazol, Ameliorates Ischemic Hindlimb Through cAMP and PPARγ Activation
36. Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats
37. Effect of Angiotensin II on Differentiation and Apoptosis of Chondrocytes in Cartilage Formation in the Process of Fracture Healing
38. Prevention of Neointimal Formation After Angioplasty Using Nuclear Factor-κB Decoy Oligodeoxynucleotide-Coated Balloon Catheter in Rabbit Model
39. Abstract W MP82: Role of OPG/RANKL/RANK System in Ischemic Brain in Mice
40. Abstract 18172: Nicotine Accelerates the Expansion of Abdominal Aortic Aneurysms via a Matricellular Protein, Periostin
41. Abstract 056: The Impact of Periostin as A Regulator of Cardiac Remodeling
42. Cross-Talk of Receptor Activator of Nuclear Factor-κB Ligand Signaling With Renin–Angiotensin System in Vascular Calcification
43. Cardiac and Renal Protective Effects of Irbesartan via Peroxisome Proliferator‐Activated Receptorγ–Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1a Receptor Blockade in Mouse Model of Salt‐Sensitive Hypertension
44. Abstract TMP111: Phenotypic Alterations of Brain Microvascular Endothelium in a Murine Model of Alzheimer Disease
45. Hepatocyte Growth Factor Inhibits Lipopolysaccharide-Induced Oxidative Stress via Epithelial Growth Factor Receptor Degradation
46. Moderate to High Concentrations of High-Density Lipoprotein From Healthy Subjects Paradoxically Impair Human Endothelial Progenitor Cells and Related Angiogenesis by Activating Rho-Associated Kinase Pathways
47. Long-Term Follow-Up Evaluation of Results From Clinical Trial Using Hepatocyte Growth Factor Gene to Treat Severe Peripheral Arterial Disease
48. 97 VALSARTAN ATTENUATES LP(A)-INDUCED SEVERE NEOINTIMAL HYPERPLASIA
49. 819 DEVELOPMENT OF ANGIOTENSIN II DNA VACCINE FOR HYPERTENSION
50. 959 PREVENTION OF NEOINTIMAL FORMATION AFTER ANGIOPLASTY USING NF-KAPPAB DECOY OLIGODEOXYNUCLEOTIDE-COATED BALLOON CATHETER IN RABBIT MODEL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.